로딩 중…
지수 로딩 중…
Organogenesis Holdings Inc.
ORGO· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$2.44+4.27%
2026-06-18
Price Chart
Organogenesis Holdings Inc.-25.38%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $314M |
| Revenue | $514M |
| Net Income | $-284000.00 |
| Total Assets | $520M |
| Net Assets | $381M |
| Value | |
| P/B | 0.82x |
| P/S | 0.61x |
| EV/EBITDA | 6.65x |
| FCF Yield | 5.44% |
| Profitability | |
| ROE | -0.07% |
| ROA | -0.05% |
| Op. Margin | 2.14% |
| Revenue Growth | -57.06% |
| Earnings Growth | 4201.05% |
| Financial Health | |
| Debt Ratio | 36.36% |
| Total Debt | $71M |
| FCF | $17M |
| Cash | $92M |
| Current Ratio | 3.53x |
| Net Debt/EBITDA | -0.48x |
| Performance | |
| 1Y Return | -25.38% |
| 1M Return | 0.41% |
| From 52W High | -65.54% |
| 1Y MDD | -65.75% |
| Trading | |
| Volume | 636,169 shares |
| Trading Value | $2M |
| Per Share | |
| EPS | $0.29 |
| BPS | $3.42 |